This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Yiming Yin: Innovator in Cancer Treatment
Introduction
Yiming Yin is a notable inventor based in Andover, MA (US), recognized for his contributions to the field of cancer treatment. With a focus on developing innovative therapies, he has made significant strides in the medical research community.
Latest Patents
Yiming Yin holds a patent for "Antibodies against MICA and/or MICB and uses thereof." This patent discloses antibodies that specifically bind to human MICA/B, providing methods for their use in treating cancer. The innovative approach involves administering an anti-MICA/B antibody to subjects, showcasing a promising avenue for cancer therapy.
Career Highlights
Yiming Yin has established himself as a key figure in the pharmaceutical industry, particularly through his work at Bristol-Myers Squibb Company. His research and development efforts have contributed to advancing medical treatments and improving patient outcomes.
Collaborations
Yiming has collaborated with esteemed colleagues, including Michelle Renee Kuhne and Alan J Korman, to further enhance the impact of his research. These partnerships have fostered a collaborative environment that encourages innovation and discovery.
Conclusion
Yiming Yin's work exemplifies the vital role of inventors in the advancement of medical science. His patent on anti-MICA/B antibodies represents a significant step forward in cancer treatment, highlighting the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile